About-cancer / lapaʻau / lāʻau / bladder
Lele i ka hoʻokele
Lele e ʻimi
Ua ʻae ʻia nā lāʻau no ka maʻi ʻaʻai Bladder
Ua helu ʻia kēia ʻaoʻao i nā lāʻau lapaʻau maʻi ʻaʻai i ʻae ʻia e ka Food and Drug Administration (FDA) no ka maʻi ʻaʻai maʻi maʻi Loaʻa i ka papa inoa nā inoa generic a me nā inoa inoa. Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau ke hoʻohana ʻia i ka maʻi ʻaʻai maʻi maʻi i helu ʻole ʻia ma aneʻi.
Ua ʻae ʻia nā lāʻau no ka maʻi ʻaʻai Bladder
Atezolizumab
ʻAvelumab
Balversa (Erdafitinib)
Bavencio (Avelumab)
ʻO Cisplatin
Doxorubicin Hydrochloride
ʻO Durvalumab
Erdafitinib
Imfinzi (Durvalumab)
Keytruda (Pembrolizumab)
ʻO Nivolumab
Opdivo (Nivolumab)
Pembrolizumab
ʻO Tecentriq (Atezolizumab)
ʻO Thiotepa
ʻO Valrubicin
Valstar (Valrubicin)
Hoʻohui ʻia nā hui lāʻau i loko o ka maʻi ʻaʻai Bladder
GEMCITABINE-CISPLATIN
MVAC